Spides, please elaborate. What do you mean when you say the "o/s R&D for Matmor is linked to final MPA due at end of this year" ?
Do you mean an overseas ruling which would enable expenses incurred in India to be claimed in OZ? and how does a commercial relationship (i.e. an agreement) affect the R&D claim? Will the rebate have to be returned when the plant is in production? You seem to be an expert on these things. I am just a retired industrial chemist who knows "stuff" and I question the basis of some of your posts.
Ann: Results of Meeting, page-16
Add ECT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $9.515M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $2.006K | 511.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 44 | 23468902 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 2862771 | 8 |
View Market Depth
| Last trade - 15.25pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.3¢ |
Change
-0.001 ( 25.0 %) |
||||
| Open | High | Low | Volume | ||
| 0.3¢ | 0.3¢ | 0.3¢ | 352136 | ||
| Last updated 15.51pm 24/05/2024 ? | |||||
| ECT (ASX) Chart |